ROUNDUP: Merck & Co will Krebsspezialisten Terns kaufen - Aktien legen zu
RAHWAY/FOSTER CITY (dpa-AFX) - Der US-Pharmakonzern Merck & Co will auf seiner Einkaufstour das Biotechunternehmen Terns Pharmaceuticals übernehmen.…
52,900$
-0,04%
Echtzeit-Aktienkurs Terns Pharmaceuticals Inc.
Bid:
Ask:
Nachrichten zur Terns Pharmaceuticals Inc. Aktie
Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline
Merck is trying to bulk up its portfolio ahead of its best-selling cancer drug Keytruda losing patent protection in 2028.…
Merck to acquire Terns Pharmaceuticals for $6.7B
Merck & Co Inc (NYSE:MRK, XETRA:6MK) announced on Wednesday that it will acquire US biotech firm Terns Pharmaceuticals (NASDAQ:TERN) for…
Terns Pharmaceuticals: Wie man mit dem Wirkstoff TERN-701 den Leukämie-Markt aufmischen will
Terns Pharmaceuticals ist ein biopharmazeutisches Unternehmen in der klinischen Entwicklungsphase. Nach dem Ausstieg aus der eigenen Adipositas-Entwicklung liegt die…
Terns Pharmaceuticals: CML Data Blows Wall Street Away - Again
…
Terns Pharmaceuticals, Inc. (TERN) Discusses Efficacy and Safety Data Update for TERN-701 in Chronic Myeloid Leukemia Transcript
…
Terns Pharmaceuticals stock soars after positive Phase 1 CML drug data By Investing.com
Terns Pharmaceuticals stock soars after positive Phase 1 CML drug data…
Terns Pharmaceuticals: Truist sieht enormes Marktpotenzial und ein attraktives CRV für die Pipeline!
Auf der Liste der Top-10 Kursziele der Analysten fällt momentan u.a. eine Terns Pharmaceuticals (TERN) positiv auf. Der Biotechnologiekonzern hat…
Terns Pharmaceuticals: A Risky Buy Ahead Of Q4 Obesity, Oncology Catalysts
…
Down -31.41% in 4 Weeks, Heres Why You Should You Buy the Dip in Terns Pharmaceuticals (TERN)
Terns Pharmaceuticals (TERN) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with…
This Weight Loss Stock Could Skyrocket by 462%, According to Wall Street
Last year, Viking Therapeutics, a mid-cap biotech, made waves after it reported excellent phase 2 results for an investigational medicine…
Terns Pharmaceuticals Appoints Heather Turner, J.D., to Board of Directors
Accomplished biotechnology CEO brings 25 years of strategic, operational, and legal experience Accomplished biotechnology CEO brings 25 years of strategic,…
Terns Pharmaceuticals: Another Potential GLP-1 Entrant
…
Terns Pharmaceuticals: Obesity Advancement Continues With Other Q1 2025 Program Catalyst
…
Missed Out on Viking Therapeutics? Buy This Weight Loss Biotech Stock Right Now.
Terns Pharmaceuticals just proved that its competitive in the weight loss field.…
Terns Announces Closing of Public Offering of Shares of Common Stock and Pre-Funded Warrants, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
FOSTER CITY, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN),…
Biotech Stock Roundup: TERN, SMMT Stocks Surge on Study Data, GSKs Vaccine Study Fails & More
Terns Pharmaceuticals and Summit Therapeutics are in the spotlight following positive updates on key candidates.…
Terns Announces Pricing of Upsized $150.15 Million Public Offering
FOSTER CITY, Calif., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN),…
Terns Pharmaceuticals: Weight Loss Drug TERN-601 Is Competitive
…
Terns (TERN) Gains 13.6% YTD: Will the Momentum Continue?
Terns Pharmaceuticals, Inc. (TERN) outperforms the industry year to date on encouraging pipeline progress of its oncology candidate.…
Terns Pharmaceuticals Announces Leadership Changes
FOSTER CITY, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN),…